Al-Hashami Z - Search Results

1

Lung cancer screening in the gulf: Rationale and recommendations.

Bennji SM, Jayakrishnan B, Al-Kindi AH, Al-Jahdhami I, Al-Hashami Z. Bennji SM, et al. Among authors: al hashami z. Ann Thorac Med. 2022 Oct-Dec;17(4):189-192. doi: 10.4103/atm.atm_69_22. Epub 2022 Oct 7. Ann Thorac Med. 2022. PMID: 36387753 Free PMC article.

2

Impact of Tumor Location on Patient Outcomes in Small Bowel Cancers.

Yu IS, Al-Hashami Z, Chapani P, Speers C, Davies JM, Lim HJ, Renouf DJ, Gill S, Stuart HC, Loree JM. Yu IS, et al. Clin Colorectal Cancer. 2022 Jun;21(2):107-113. doi: 10.1016/j.clcc.2021.11.006. Epub 2021 Dec 1. Clin Colorectal Cancer. 2022. PMID: 34972663

3

Pulmonary toxicities of immune check point inhibitors in the management of cancer: mini review.

Jayakrishnan B, Al-Moundhri M, Burney I, Al-Hashami Z, Al-Bimani K. Jayakrishnan B, et al. Among authors: al hashami z. Adv Respir Med. 2022;90(3):219-229. doi: 10.5603/ARM.84782. Adv Respir Med. 2022. PMID: 35731114 Free article. Review.

4

Adenocarcinoma of lung presenting as diffuse interstitial lung disease.

Jayakrishnan B, Burney I, Osman AH, Bennji SM, Al-Hashami Z. Jayakrishnan B, et al. Among authors: al hashami z. Lancet Oncol. 2023 Jul;24(7):e323. doi: 10.1016/S1470-2045(23)00224-3. Lancet Oncol. 2023. PMID: 37414021 No abstract available.

5

Real-world eligibility for platinum doublet plus immune checkpoint inhibitors in extensive-stage small-cell lung cancer.

Rittberg R, Leung B, Al-Hashami Z, Ho C. Rittberg R, et al. Among authors: al hashami z. Front Oncol. 2022 Sep 15;12:1002385. doi: 10.3389/fonc.2022.1002385. eCollection 2022. Front Oncol. 2022. PMID: 36185266 Free PMC article.

6

Real World Patient Eligibility for Second Line Lurbinectedin Based Treatment in Small Cell Lung Cancer: Understanding Epidemiology and Estimating Health Care Utilization.

Rittberg R, Leung B, Al-Hashami Z, Ho C. Rittberg R, et al. Among authors: al hashami z. Curr Oncol. 2022 Dec 8;29(12):9744-9752. doi: 10.3390/curroncol29120765. Curr Oncol. 2022. PMID: 36547179 Free PMC article.

7

Improved uptake and survival with systemic treatments for metastatic non-small cell lung cancer: younger versus older adults.

Leung B, Shokoohi A, Al-Hashami Z, Moore S, Pender A, Wong SK, Wang Y, Wu J, Ho C. Leung B, et al. Among authors: al hashami z. BMC Cancer. 2023 Apr 19;23(1):360. doi: 10.1186/s12885-023-10800-x. BMC Cancer. 2023. PMID: 37076834 Free PMC article.

8

Hepatocellular Carcinoma in Oman: An analysis of 284 cases.

Al-Naamani K, Al-Hashami Z, Al-Siyabi O, Al-Moundri M, Al-Bahrani B, Al-Sinani S, Al-Zakwani I, Omar H, Al-Busafi SA, Al-Zuhaibi H, AlMamari A, Kamath BR, Al-Kalbani A, Burney IA. Al-Naamani K, et al. Sultan Qaboos Univ Med J. 2020 Aug;20(3):e316-e322. doi: 10.18295/squmj.2020.20.03.011. Epub 2020 Oct 5. Sultan Qaboos Univ Med J. 2020. PMID: 33110647 Free PMC article.

9

Alternate Pembrolizumab Dosing Interval in Advanced NSCLC with PD-L1 TPS ≥ 50%: 3 Weekly Compared to 6 Weekly Dosing.

Jones L, Rittberg R, Leung B, Shokoohi A, Pender A, Wong S, Al-Hashami Z, Wang Y, Ho C. Jones L, et al. Among authors: al hashami z. Curr Oncol. 2022 Nov 15;29(11):8686-8692. doi: 10.3390/curroncol29110685. Curr Oncol. 2022. PMID: 36421338 Free PMC article.

10

The Prevalence and Patterns of Toxicity With Immune Checkpoint Inhibitors in Solid Tumors: A Real-World Experience From a Tertiary Care Center in Oman.

Salman B, AlWard NM, Al-Hashami Z, Al-Sharqi H, Al-Sayegh H, Burney IA. Salman B, et al. Among authors: al hashami z. Cureus. 2023 Oct 15;15(10):e47050. doi: 10.7759/cureus.47050. eCollection 2023 Oct. Cureus. 2023. PMID: 38021572 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page